Meta-analysis and public policy: Reconciling the evidence on deworming

Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2308733121. doi: 10.1073/pnas.2308733121. Epub 2024 Jun 10.

Abstract

The WHO recommends mass drug administration (MDA) for intestinal worm infections in areas with over 20% infection prevalence. Recent Cochrane meta-analyses endorse treatment of infected individuals but recommend against MDA. We conducted a theory-agnostic random-effects meta-analysis of the effect of multiple-dose MDA and a cost-effectiveness analysis. We estimate significant effects of MDA on child weight (0.15 kg, 95% CI: 0.07, 0.24; P < 0.001), mid-upper arm circumference (0.20 cm, 95% CI: 0.03, 0.37; P = 0.02), and height (0.09 cm, 95% CI: 0.01, 0.16; P = 0.02) when prevalence is over 20% but not on Hb (0.06 g/dL, 95% CI: -0.01, 0.14; P = 0.1). These results suggest that MDA is a cost-effective intervention, particularly in the settings where it is recommended by the WHO.

Keywords: cost-effectiveness; deworming; meta-analysis; nutrition.

Publication types

  • Meta-Analysis

MeSH terms

  • Anthelmintics / administration & dosage
  • Anthelmintics / therapeutic use
  • Child
  • Cost-Benefit Analysis
  • Helminthiasis* / drug therapy
  • Helminthiasis* / epidemiology
  • Humans
  • Intestinal Diseases, Parasitic* / drug therapy
  • Intestinal Diseases, Parasitic* / epidemiology
  • Mass Drug Administration
  • Public Policy

Substances

  • Anthelmintics

Supplementary concepts

  • Intestinal helminthiasis